Agile Therapeutics (AGRX) Earnings Date, Estimates & Call Transcripts → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free AGRX Stock Alerts $0.36 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryLatest Earnings DateMay. 15EstimatedActual EPS (May. 15) -$0.63 Missed By -$0.63 Read Call Transcript Get Agile Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for AGRX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAGRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AGRX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details… AGRX Earnings Date and InformationAgile Therapeutics last announced its quarterly earnings data on May 15th, 2024. The specialty pharmaceutical company reported ($0.63) earnings per share for the quarter. The business had revenue of $5.72 million for the quarter. Agile Therapeutics has generated ($3.65) earnings per share over the last year (($3.65) diluted earnings per share). Read More Agile Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript5/15/2024Q1 2024-($0.63)($0.63)($1.54)-$5.72 million 3/28/2024Q4 2023-($1.46)($1.46)($1.41)-$3.62 million11/9/2023Q3 2023-($1.47)($1.47)($2.67)-$6.66 million8/9/2023Q2 2023($3.48)($3.10)+$0.38($4.05)$4.68 million$5.50 million5/11/2023Q1 2023-($7.76)($7.76)($9.61)-$3.81 million3/22/2023Q4 2022($10.50)($9.00)+$1.50($13.00)$3.17 million$4.00 million Get the Latest News and Ratings for AGRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Agile Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/7/2022Q3 2022($0.30)($0.23)+$0.07$0.07$2.46 million$3.00 million8/11/2022Q2 2022-($2.71)($2.71)($2.71)$2.13 million$2.13 million 5/12/2022Q1 2022-($3.78)($3.78)($3.78)-$1.76 million3/30/2022Q4 2021($6.80)($8.00)($1.20)($0.20)$1.58 million$1.51 million 11/2/2021Q3 2021($7.60)($7.20)+$0.40($0.18)$1.49 million$1.29 million 7/25/2021Q2 2021($8.80)($8.00)+$0.80($0.20)$1.45 million$1.19 million 5/3/2021Q1 2021($8.40)($8.00)+$0.40($0.20)$0.65 million$0.12 million 2/28/2021Q4 2020($8.80)($8.00)+$0.80($0.20)$1.01 million$0.75 million 11/17/2020Q3 2020($7.20)($7.20)-($0.18)-- 8/11/2020Q2 2020($5.60)($4.80)+$0.80($0.12)-- 5/5/2020Q1 2020($3.60)($4.1136)($0.5136)($0.10)-- 2/20/2020Q4($3.00)($4.00)($1.00)($0.10)--10/28/2019Q3 2019($3.28)($3.3069)($0.0269)($0.08)--8/1/2019Q2 2019($4.52)($3.1834)+$1.3366($0.08)-- Agile Therapeutics Earnings - Frequently Asked Questions When did Agile Therapeutics announce their last quarterly earnings? Agile Therapeutics (NASDAQ:AGRX) last announced its quarterly earning data on Wednesday, May 15, 2024. Learn more on AGRX's earnings history. How can I read Agile Therapeutics's conference call transcript? The conference call transcript for Agile Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Agile Therapeutics generate each year? Agile Therapeutics (NASDAQ:AGRX) has a recorded annual revenue of $19.59 million. How much profit does Agile Therapeutics generate each year? Agile Therapeutics (NASDAQ:AGRX) has a recorded net income of -$14.47 million. AGRX has generated -$3.65 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: CNS Pharmaceuticals Earnings Aridis Pharmaceuticals Earnings Aravive Earnings Onconetix Earnings Quoin Pharmaceuticals Earnings Longeveron Earnings Sonoma Pharmaceuticals Earnings Salarius Pharmaceuticals Earnings Avenue Therapeutics Earnings Lucy Scientific Discovery Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Hormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New HeightsTD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China? This page (NASDAQ:AGRX) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressBiden Nomination CANCELED?The Freeport Society“This will be one of the biggest revolutions ever.” - NVIDIA CEOBehind the MarketsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agile Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
